Kyowa Kirin

Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of innovative medicines, with a growing portfolio in rare diseases and therapeutic areas with high medical needs. With headquarters in Scotland, Kyowa Kirin International has business operations throughout Europe and the United States.

Kyowa Kirin International is a wholly owned subsidiary of Japan-based Kyowa Hakko Kirin Co. Ltd., a leading research-based life sciences company with particular strength in antibody technologies for oncology, nephrology and immunology/allergy. Through its research and global commercialisation of innovative medicines, the company seeks to contribute to the health and wellbeing of people around the world.